Market Cap 55.30B
Revenue (ttm) 21.84B
Net Income (ttm) 1.68B
EPS (ttm) N/A
PE Ratio 13.42
Forward PE 13.04
Profit Margin 7.68%
Debt to Equity Ratio 0.69
Volume 1,784,700
Avg Vol 2,110,038
Day's Range N/A - N/A
Shares Out 285.42M
Stochastic %K 68%
Beta 0.25
Analysts Sell
Price Target $200.40

Company Profile

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 201 847 6800
Website: www.bd.com
Address:
1 Becton Drive, Franklin Lakes, United States
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 1:39 AM
Actionable Trade Alert for $BDX: Market Context: The last close for $BDX is $193.76, sitting near the 60D high of $196.36. The RSI of 51.49 indicates a neutral stance, suggesting potential for upward movement without being overbought. The MA30 and MA50 are both below the current price, indicating short-term bullish momentum. Directional Bias: Given the proximity to the 60D high and the neutral RSI, we maintain a bullish bias. The price is above both the MA30 and MA50, which supports this outlook. Trade Plan: - Suggested Entry: $194.50 - Stop Loss: $190.00 (3.5% below entry) - Take Profit Targets: 1. $198.00 (1.9% gain) 2. $201.00 (3.3% gain) 3. $227.00 (16.7% gain) With the potential to exceed a 17% ROI at the third target, this trade offers a favorable risk-reward ratio. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
ZacksResearch
ZacksResearch Dec. 5 at 5:34 PM
$BDX strikes a new partnership — what does it mean for investors? 🤔 $BDX teams up with ChemoGLO to enhance drug contamination testing, aiming to boost its MDS business unit and strengthen market position. The collaboration is expected to speed up and improve safety measures in healthcare settings. Discover the potential impact on BD's future here 👉 https://www.zacks.com/stock/news/2800517/bd-stock-up-post-tie-up-to-expand-hazardous-drug-contamination-testing?cid=sm-stocktwits-2-2800517-body-23690&ADID=SYND_STOCKTWITS_TWEET_2_2800517_BODY_23690
0 · Reply
ZacksResearch
ZacksResearch Dec. 5 at 4:34 PM
$BDX popping after a smart strategic tie-up. The company’s teaming with ChemoGLO to expand hazardous drug contamination testing — a clear push to strengthen safety across healthcare environments. Get the full breakdown here 👉 https://www.zacks.com/stock/news/2800517/bd-stock-up-post-tie-up-to-expand-hazardous-drug-contamination-testing?cid=sm-stocktwits-2-2800517-teaser-23668&ADID=SYND_STOCKTWITS_TWEET_2_2800517_TEASER_23668
0 · Reply
RonIsWrong
RonIsWrong Dec. 5 at 3:26 PM
$BDX should pay well if this breaks out
0 · Reply
RonIsWrong
RonIsWrong Dec. 4 at 2:54 PM
$BDX 👀 unusual options activity 10K March $220 calls
0 · Reply
HedgeAlerts
HedgeAlerts Dec. 4 at 7:55 AM
Hedge Alert Live - Protect Your Portfolio Contract: $BDX $190.00 Put · DEC 19, 2025 Exp Entry Price: $2.64 - $2.85 Exit Price Target: $4.99 Profit Margin: +89% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
erevnon
erevnon Dec. 2 at 6:29 PM
Morgan Stanley maintains Becton Dickinson $BDX at Overweight and raises the price target from $197 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
JarvisFlow
JarvisFlow Dec. 2 at 5:29 PM
Morgan Stanley updates rating for Becton Dickinson ( $BDX ) to Overweight, target set at 197 → 210.
0 · Reply
HedgeAlerts
HedgeAlerts Dec. 1 at 10:48 PM
Hedge Alert Live - Protect Your Portfolio Contract: $BDX $190.00 Put · DEC 19, 2025 Exp Entry Price: $2.70 - $3.20 Exit Price Target: $5.02 Profit Margin: +86% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 1 at 4:13 PM
$BDX Current Stock Price: $192.94 Contracts to trade: $195 BDX Dec 19 2025 Call Entry: $2.50 Exit: $3.96 ROI: 58% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Latest News on BDX
Best Dividend Aristocrats For December 2025

Nov 29, 2025, 8:02 AM EST - 6 days ago

Best Dividend Aristocrats For December 2025

ABBV ABT ADM ADP AFL ALB AMCR


BD Board Increases Dividend for 54th Consecutive Year

Nov 6, 2025, 6:25 AM EST - 4 weeks ago

BD Board Increases Dividend for 54th Consecutive Year


Best Dividend Aristocrats For November 2025

Nov 1, 2025, 10:25 AM EDT - 4 weeks ago

Best Dividend Aristocrats For November 2025

ABBV ABT ADM ADP AMCR AOS ATO


Best Dividend Kings: October 2025

Oct 29, 2025, 5:11 AM EDT - 5 weeks ago

Best Dividend Kings: October 2025

ABBV ABM ABT ADM ADP AWR BKH


Becton Dickinson's CFO to depart

Oct 15, 2025, 4:42 PM EDT - 7 weeks ago

Becton Dickinson's CFO to depart


BD Announces CFO Transition Plan

Oct 15, 2025, 4:15 PM EDT - 7 weeks ago

BD Announces CFO Transition Plan


Best Dividend Aristocrats For October 2025

Sep 28, 2025, 1:00 AM EDT - 2 months ago

Best Dividend Aristocrats For October 2025

ABT ADP ATO BEN CAH CHRW CL


Best Dividend Aristocrats For September 2025

Aug 27, 2025, 2:09 PM EDT - 3 months ago

Best Dividend Aristocrats For September 2025

ABBV ABT ADM ADP AFL ALB AMCR


Best Dividend Kings: August 2025

Aug 24, 2025, 10:13 PM EDT - 3 months ago

Best Dividend Kings: August 2025

ABBV ABM ABT ADM AWR BKH CINF


Becton, Dickinson: Great Time To Buy This Dividend Aristocrat

Aug 18, 2025, 8:00 AM EDT - 3 months ago

Becton, Dickinson: Great Time To Buy This Dividend Aristocrat


BD to Present at Wells Fargo 2025 Healthcare Conference

Aug 14, 2025, 4:15 PM EDT - 4 months ago

BD to Present at Wells Fargo 2025 Healthcare Conference


Becton Dickinson Q3 Beats Estimates On Medical Device Boom

Aug 7, 2025, 11:40 AM EDT - 4 months ago

Becton Dickinson Q3 Beats Estimates On Medical Device Boom


BD Reports Third Quarter Fiscal 2025 Financial Results

Aug 7, 2025, 6:30 AM EDT - 4 months ago

BD Reports Third Quarter Fiscal 2025 Financial Results


PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 1:39 AM
Actionable Trade Alert for $BDX: Market Context: The last close for $BDX is $193.76, sitting near the 60D high of $196.36. The RSI of 51.49 indicates a neutral stance, suggesting potential for upward movement without being overbought. The MA30 and MA50 are both below the current price, indicating short-term bullish momentum. Directional Bias: Given the proximity to the 60D high and the neutral RSI, we maintain a bullish bias. The price is above both the MA30 and MA50, which supports this outlook. Trade Plan: - Suggested Entry: $194.50 - Stop Loss: $190.00 (3.5% below entry) - Take Profit Targets: 1. $198.00 (1.9% gain) 2. $201.00 (3.3% gain) 3. $227.00 (16.7% gain) With the potential to exceed a 17% ROI at the third target, this trade offers a favorable risk-reward ratio. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
ZacksResearch
ZacksResearch Dec. 5 at 5:34 PM
$BDX strikes a new partnership — what does it mean for investors? 🤔 $BDX teams up with ChemoGLO to enhance drug contamination testing, aiming to boost its MDS business unit and strengthen market position. The collaboration is expected to speed up and improve safety measures in healthcare settings. Discover the potential impact on BD's future here 👉 https://www.zacks.com/stock/news/2800517/bd-stock-up-post-tie-up-to-expand-hazardous-drug-contamination-testing?cid=sm-stocktwits-2-2800517-body-23690&ADID=SYND_STOCKTWITS_TWEET_2_2800517_BODY_23690
0 · Reply
ZacksResearch
ZacksResearch Dec. 5 at 4:34 PM
$BDX popping after a smart strategic tie-up. The company’s teaming with ChemoGLO to expand hazardous drug contamination testing — a clear push to strengthen safety across healthcare environments. Get the full breakdown here 👉 https://www.zacks.com/stock/news/2800517/bd-stock-up-post-tie-up-to-expand-hazardous-drug-contamination-testing?cid=sm-stocktwits-2-2800517-teaser-23668&ADID=SYND_STOCKTWITS_TWEET_2_2800517_TEASER_23668
0 · Reply
RonIsWrong
RonIsWrong Dec. 5 at 3:26 PM
$BDX should pay well if this breaks out
0 · Reply
RonIsWrong
RonIsWrong Dec. 4 at 2:54 PM
$BDX 👀 unusual options activity 10K March $220 calls
0 · Reply
HedgeAlerts
HedgeAlerts Dec. 4 at 7:55 AM
Hedge Alert Live - Protect Your Portfolio Contract: $BDX $190.00 Put · DEC 19, 2025 Exp Entry Price: $2.64 - $2.85 Exit Price Target: $4.99 Profit Margin: +89% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
erevnon
erevnon Dec. 2 at 6:29 PM
Morgan Stanley maintains Becton Dickinson $BDX at Overweight and raises the price target from $197 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
JarvisFlow
JarvisFlow Dec. 2 at 5:29 PM
Morgan Stanley updates rating for Becton Dickinson ( $BDX ) to Overweight, target set at 197 → 210.
0 · Reply
HedgeAlerts
HedgeAlerts Dec. 1 at 10:48 PM
Hedge Alert Live - Protect Your Portfolio Contract: $BDX $190.00 Put · DEC 19, 2025 Exp Entry Price: $2.70 - $3.20 Exit Price Target: $5.02 Profit Margin: +86% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 1 at 4:13 PM
$BDX Current Stock Price: $192.94 Contracts to trade: $195 BDX Dec 19 2025 Call Entry: $2.50 Exit: $3.96 ROI: 58% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
d_risk
d_risk Nov. 26 at 3:13 PM
$BDX - Becton Dickinson and Company Common Stock - 10K - Updated Risk Factors BDX’s 2025 10-K risk factors spotlight heightened macroeconomic, geopolitical, and supply chain pressures; expanded threats from tech competitors and shifting healthcare policy; new and detailed AI, sustainability, and regulatory risks; increased legal, operational, and integration challenges; and significant uncertainties tied to the proposed Waters combination. #Healthcare #Geopolitical #Regulatory #AIRisks #SupplyChain 🟢 Added 🟠 Removed https://d-risk.ai/BDX/10-K/2025-11-25
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 26 at 3:04 AM
Hedge Alert Live - Protect Your Portfolio Contract: $BDX $195.00 Put · DEC 19, 2025 Exp Entry Price: $5.40 - $6.40 Exit Price Target: $9.02 Profit Margin: +41% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 25 at 3:04 AM
Hedge Alert Live - Protect Your Portfolio Contract: $BDX $190.00 Put · DEC 19, 2025 Exp Entry Price: $3.56 - $4.10 Exit Price Target: $8.47 Profit Margin: +138% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 25 at 1:36 AM
$BDX Share Price: $191.02 Contract Selected: Jun 18, 2026 $190 Calls Buy Zone: $12.66 – $15.65 Target Zone: $23.99 – $29.33 Potential Upside: 79% ROI Time to Expiration: 205 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
11thestate
11thestate Nov. 24 at 5:09 PM
If you missed the deadline, don’t miss this update. This is probably the most useful info you’ve read in years about $BDX — how you can actually recover something: https://11th.com/cases/bdx-shareholder-settlement
0 · Reply
smartkarma
smartkarma Nov. 24 at 4:50 AM
$BDX | New BD Looks Cheap But I’m Not Ready to Buy (Yet) "In Q1 2026, BDX will merge its Biosciences & Diagnostic Solutions segment to Waters (WAT). BDX will receive $4BN in cash and 0.14 WAT shares..." - Richard Howe (Stock Spin-Off Investing) Read more: https://www.smartkarma.com/insights/new-bd-looks-cheap-but-i-m-not-ready-to-buy-yet
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 23 at 4:27 AM
Hedge Alert Live - Protect Your Portfolio Contract: $BDX $190.00 Put · DEC 19, 2025 Exp Entry Price: $4.10 - $4.80 Exit Price Target: $5.99 Profit Margin: +46% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 21 at 11:50 PM
Hedge Alert Live - Protect Your Portfolio Contract: $BDX $190.00 Put · DEC 19, 2025 Exp Entry Price: $4.10 - $4.80 Exit Price Target: $5.99 Profit Margin: +46% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 21 at 12:00 AM
Hedge Alert Live - Protect Your Portfolio Contract: $BDX $185.00 Put · DEC 19, 2025 Exp Entry Price: $3.60 - $3.80 Exit Price Target: $6.38 Profit Margin: +68% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 20 at 8:02 AM
Hedge Alert Live - Protect Your Portfolio Contract: $BDX $190.00 Put · DEC 19, 2025 Exp Entry Price: $5.10 - $5.35 Exit Price Target: $10.86 Profit Margin: +113% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 19 at 9:51 PM
Hedge Alert Live - Protect Your Portfolio Contract: $BDX $190.00 Put · DEC 19, 2025 Exp Entry Price: $5.65 - $6.20 Exit Price Target: $9.72 Profit Margin: +72% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
christophernorton
christophernorton Nov. 19 at 4:27 AM
$XPEV $RIO $BDX $SLB Market sentiment has turned optimistic, triggering a sharp rally. https://stocktwits.com/adoniscaroline/message/636687233
0 · Reply